Novel HGSNAT Variants Identified in the Oldest Siblings With MPS IIIC : Functional Characterization and Literature Review
- 25 March 2026
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
Abstract
Mucopolysaccharidosis type IIIC (MPS IIIC) is a rare lysosomal storage disorder caused by biallelic pathogenic variants in the HGSNAT gene, encoding heparan‐α‐glucosaminide N‐acetyltransferase. Deficient enzymatic activity leads to heparan sulfate accumulation, resulting in progressive central nervous system involvement and multisystem disease. Clinical features typically include developmental delay, intellectual disability, behavioral disturbances, coarse facial features, hypertrichosis, and hearing loss. This report describes the oldest documented siblings with MPS IIIC: a male diagnosed at 46 years (currently 50 years) and his sister diagnosed at 38 years (currently 42 years). Both presented with bilateral sensorineural hearing loss, retinitis pigmentosa, intellectual disability, mildly coarse facial features, and hypertrichosis. Molecular analysis identified two novel HGSNAT variants: c.1205T>C; p.(Leu402Pro) and c.1565C>A; p.(Thr522Lys). Functional studies demonstrated markedly reduced heparan‐α‐glucosaminide N‐acetyltransferase activity and elevated urinary heparan sulfate excretion, providing biochemical evidence supporting variant pathogenicity and confirming the diagnosis. These cases expand both the phenotypic and genotypic spectrum of MPS IIIC and underscore the importance of considering this disorder in adults with multisystem involvement. Functional characterization proved essential for establishing a definitive diagnosis when molecular findings alone were inconclusive.Keywords
This publication has 45 references indexed in Scilit:
- AAV gene replacement therapy for treating MPS IIIC: Facilitating bystander effects via EV‐mRNA cargoJournal of Extracellular Vesicles, 2024
- Clinical, biochemical, and molecular characterization of mucopolysaccharidosis type III in 34 Egyptian patientsAmerican Journal of Medical Genetics Part A, 2023
- Adults with lysosomal storage diseases in the undiagnosed diseases networkMolecular Genetics & Genomic Medicine, 2022
- Molecular characterization of a large group of Mucopolysaccharidosis type IIIC patients reveals the evolutionary history of the diseaseHuman Mutation, 2019
- Mucopolysaccharidosis III in Taiwan: Natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21‐year periodAmerican Journal of Medical Genetics Part A, 2018
- PERCH: A Unified Framework for Disease Gene PrioritizationHuman Mutation, 2016
- Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and GreeceAmerican Journal of Medical Genetics Part A, 2010
- Mucopolysaccharidosis type IIIA: Clinical spectrum and genotype‐phenotype correlationsAnnals of Neurology, 2010
- Sanfilippo syndrome type C: mutation spectrum in the heparan sulfate acetyl-CoA: α-glucosaminide N-acetyltransferase (HGSNAT) geneHuman Mutation, 2009
- Mutational analysis of theHGSNATgene in Italian patients with mucopolysaccharidosis IIIC (Sanfilippo C syndrome)Human Mutation, 2007